Search for: "State v. Tri-State Pharmaceutical" Results 421 - 440 of 456
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 May 2017, 10:22 am by Schachtman
The case, which has gained this recent notoriety is Lois Slemp v. [read post]
21 Oct 2011, 1:31 pm by SteinMcewen, LLP
§102(a).[24] As an illustration of how this might represent a change, lets look at the facts in Motionless Keyboard Co. v. [read post]
9 Nov 2015, 7:39 am
Merck Sharp & Dohme v Ono Pharmaceutical [2015] EWHC 2973 (Pat), decided on 22 October by Mr Justice Birss in the Patents Court, England and Wales, is a decidedly unbifurcated ruling, being a full-blooded infringement-and-invalidity action running to 243 paragraphs. [read post]
21 May 2010, 8:58 am by Eric Guttag
 See Not Losing the Forest for the Trees: Newman Concurs in Ariad where Newman’s concurring opinion concisely captured the essence (and not simply the form) of the “written description” requirement, and why the patent in Ariad Pharmaceuticals v. [read post]
27 Oct 2007, 4:02 pm
You'll get to learn how they tried that case and how they obtained that verdict. [read post]
31 Dec 2016, 12:05 am by Jeffrey May
Penn State Hershey Medical Center and Pinnacle Health System called off plans to merge after the U.S. [read post]
29 Dec 2009, 5:46 pm by smtaber
— Mireya Navarroa, The New York Times, December 22, 2009 Air quality in the New York tri-state region stands to benefit from a court settlement requiring Duke Energy, one of the nation’s largest electric power companies, to drastically cut sulfur dioxide emissions from a coal-fired plant in Indiana, state and federal officials said Tuesday. [read post]
29 Dec 2009, 5:50 pm by admin
— Mireya Navarroa, The New York Times, December 22, 2009 Air quality in the New York tri-state region stands to benefit from a court settlement requiring Duke Energy, one of the nation’s largest electric power companies, to drastically cut sulfur dioxide emissions from a coal-fired plant in Indiana, state and federal officials said Tuesday. [read post]
29 Aug 2016, 1:19 pm by Michael Grossman
While Janssen Pharmaceutical and Johnson & Johnson can be held liable for the damages caused by Risperdal and Invega, a 2011 decision by the United States Supreme Court protects most makers of generic risperidone/paloperidone from litigation. [read post]
12 Apr 2019, 2:35 pm by opseo
The debtors received a refund of $684 from the state on July 9, 2009. [read post]
15 Oct 2012, 8:13 am by Charles Johnson
(ETS), raised capital to grow his coin-operated payphone business by using a network of independent insurance agents to sell payphones to investors throughout the United States for $5,000 to $7,000 per phone. [read post]
25 Jan 2024, 5:31 am by Ashley Morgan
  Another is that you may have tried all approved treatments without seeing any benefits. [read post]
12 Feb 2024, 6:07 am by Kevin LaCroix
The Health Plan Excess Fee Case Filed Against Johnson and Johnson In Lewandowski v. [read post]